Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct;39(10):e70332.
doi: 10.1111/ctr.70332.

Baseline Vascular Pathology in Deceased Donor Kidneys: Differential Impact on Transplant Outcomes by Donor Type

Affiliations

Baseline Vascular Pathology in Deceased Donor Kidneys: Differential Impact on Transplant Outcomes by Donor Type

Junichiro Sageshima et al. Clin Transplant. 2025 Oct.

Abstract

Background: The impact of kidney vascular pathology on transplant outcomes remains poorly understood, particularly under specific donor conditions.

Methods: This retrospective single-center study analyzed 837 deceased donor kidney transplants. Based on baseline vascular histology, the kidneys were categorized into two groups: minimal vascular disease (Group 0, n = 637) and significant vascular disease (Group 1, n = 200). Five-year graft survival and 6- and 12-month kidney function were evaluated, along with subgroup analyses of various donor characteristics. Propensity score matching was used to adjust for confounding factors.

Results: Recipients of kidneys with significant vascular disease showed worse 5-year overall graft survival (64.6% vs. 80.0%, p = 0.0002) and death-censored graft survival (85.6% vs. 91.5%, p = 0.0126). These differences persisted after propensity score matching. The impact was most pronounced in hypertensive donors (53.4% vs. 84.9%) and diabetic donors (52.3% vs. 69.0%). Circulatory death donors showed immediate adverse effects, while brain death donors demonstrated delayed deterioration. Kidneys with significant vascular disease exhibited lower glomerular filtration rates at follow-up.

Conclusion: Baseline vascular disease in deceased donor kidneys has a significant impact on transplant outcomes, independent of clinical risk factors. These findings support the incorporation of vascular histological assessment into donor evaluation to enhance risk stratification and optimize post-transplant management.

Keywords: biopsy; deceased donors; kidney transplantation; transplantation outcomes; vascular diseases.

PubMed Disclaimer

References

    1. P. Jadav, S. Mohan, and S. A. Husain, “Role of Deceased Donor Kidney Procurement Biopsies in Organ Allocation,” Current Opinion in Nephrology and Hypertension 30, no. 6 (2021): 571–576, https://doi.org/10.1097/MNH.0000000000000746.
    1. C. J. Wang, J. B. Wetmore, G. S. Crary, and B. L. Kasiske, “The Donor Kidney Biopsy and Its Implications in Predicting Graft Outcomes: A Systematic Review,” American Journal of Transplantation 15, no. 7 (2015): 1903–1914, https://doi.org/10.1111/ajt.13213.
    1. S. M. Cockfield, R. B. Moore, G. Todd, K. Solez, and S. Gourishankar, “The Prognostic Utility of Deceased Donor Implantation Biopsy in Determining Function and Graft Survival After Kidney Transplantation,” Transplantation 89, no. 5 (2010): 559–566, https://doi.org/10.1097/TP.0b013e3181ca7e9b.
    1. E. Pokorna, S. Vitko, M. Chadimova, and O. Schuck, “Adverse Effect of Donor Arteriolosclerosis On Graft Outcome After Renal Transplantation,” Nephrology, Dialysis, Transplantation 15, no. 5 (2000): 705–710, https://doi.org/10.1093/ndt/15.5.705.
    1. L. K. Kayler, R. Mohanka, A. Basu, R. Shapiro, and P. S. Randhawa, “Correlation of Histologic Findings on Preimplant Biopsy With Kidney Graft Survival,” Transplant International 21, no. 9 (2008): 892–898, https://doi.org/10.1111/j.1432‐2277.2008.00681.x.

MeSH terms

LinkOut - more resources